Akdital Valuation

Q: What is the Fair Price of AKT when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

AKT (MAD1072) is trading above our estimate of [[fair value]] (MAD669.64)

Is AKT undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of AKT when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: AKT (MAD1072) is trading above our estimate of fair value (MAD669.64)

Significantly Below Fair Value: AKT is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for AKT?

Key metric: As AKT is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for AKT. This is calculated by dividing AKT's market cap by their current earnings.
What is AKT's PE Ratio?
PE Ratio	68.8x
Earnings	د.م220.64m
Market Cap	د.م15.18b

AKT key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	7x
Enterprise Value/EBITDA	24.6x
PEG Ratio	1.5x

Price to Earnings Ratio vs Peers

How does AKT's PE Ratio compare to its peers?

The above table shows the PE ratio for AKT vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	43.1x
USPH U.S. Physical Therapy	104.7x	29.4%	US$1.5b
LHC Life Healthcare Group Holdings	17.5x	13.9%	R24.7b
4007 Al Hammadi Holding	19.4x	9.4%	ر.س6.3b
4009 Middle East Healthcare	30.7x	21.4%	ر.س6.5b
AKT Akdital	68.8x	45.7%	د.م15.2b

Price-To-Earnings vs Peers: AKT is expensive based on its Price-To-Earnings Ratio (68.8x) compared to the peer average (43.1x).

Price to Earnings Ratio vs Industry

How does AKT's PE Ratio compare vs other companies in the Global Healthcare Industry?

11 Companies	Price / Earnings	Estimated Growth	Market Cap

11 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: AKT is expensive based on its Price-To-Earnings Ratio (68.8x) compared to the Global Healthcare industry average (20.6x).

Price to Earnings Ratio vs Fair Ratio

What is AKT's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

AKT PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	68.8x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate AKT's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst AKT forecast and predictions for the stock price in 12 month’s time.
Date	Share Price	Average 1Y Price Target	Dispersion	High	Low	1Y Actual price	Analysts
Current	د.م1,072.00	د.م1,127.00 +5.1%	0.7%	د.م1,135.00	د.م1,119.00	n/a	2
Nov ’25	د.م1,030.00	د.م1,127.00 +9.4%	0.7%	د.م1,135.00	د.م1,119.00	n/a	2
Jun ’25	د.م674.00	د.م448.50 -33.5%	19.1%	د.م534.00	د.م363.00	n/a	2
May ’25	د.م720.20	د.م448.50 -37.7%	19.1%	د.م534.00	د.م363.00	n/a	2
Apr ’25	د.م676.00	د.م448.50 -33.7%	19.1%	د.م534.00	د.م363.00	n/a	2
Mar ’25	د.م690.00	د.م448.50 -35.0%	19.1%	د.م534.00	د.م363.00	n/a	2
Dec ’24	د.م492.00	د.م448.50 -8.8%	19.1%	د.م534.00	د.م363.00	n/a	2
Nov ’24	د.م505.00	د.م448.50 -11.2%	19.1%	د.م534.00	د.م363.00	د.م1,030.00	2
Oct ’24	د.م479.00	د.م448.50 -6.4%	19.1%	د.م534.00	د.م363.00	د.م1,048.00	2

Analyst Forecast: Target price is less than 20% higher than the current share price.